A preventable illness that hospitalises healthy children, devastates pregnant women, and kills immunocompromised kids is not harmless. It is a public health failure.
MOH continues to recommend universal hepatitis B vaccination for babies at birth, saying hepatitis B birth dose vaccination in Malaysia has proven effective since 1989 in curbing infections among children. Parents are reminded to follow the NIP schedule.
In response to the US CDC recommending an end to the universal birth-dose of the hepatitis B vaccine, Malaysian doctors note that virtually every newborn in Malaysia receives the hep B vaccine birth-dose, with hep B seroprevalence dropping by over 80%.
With vigilant monitoring and coordinated action, Malaysia stands on the threshold of a new era in dengue prevention — one guided by science, strategy, and sustained hope.
Health Minister Dzulkefly Ahmad said the Qdenga vaccine won’t be added to the NIP yet, as Malaysia hasn’t met WHO’s 60% seroprevalence threshold in children. The government will instead expand Wolbachia mosquito use, which has shown 45–100% effectiveness.
Just like influenza, updated Covid-19 vaccines must be allocated in Budget 2025 for the elderly and other high-risk groups. It would be cost-effective for MOH to run annual routine inoculation programmes for senior citizens, combining flu and Covid shots.